Novel mechanisms of tubulointerstitial injury in IgA nephropathy: A new therapeutic paradigm in the prevention of progressive renal failure

Clinical and Experimental Nephrology

Volumn 8, Issue 4, 2004, Pages 297-303

  Chan, Loretta Y Y ^a   Leung, Joseph C K ^a   Lai, Kar Neng ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Angiotensin II; Angiotensin II subtype 1 receptor; Angiotensin II subtype 2 receptor; Glomerulotubular crosstalk; IgA nephropathy; Mesangial cells; Polymeric IgA; Proximal tubular epithelial cells; Tubulointerstitial injury

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HUMORAL ANTIBODY; IMMUNOGLOBULIN A; ISOPROTEIN; L 805645; LOSARTAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;

APOPTOSIS; CELL ACTIVATION; CELL INFILTRATION; DISEASE COURSE; DRUG EFFECT; EPITHELIUM CELL; GLOMERULUS; GROWTH INHIBITION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN DEPOSITION; KIDNEY FAILURE; KIDNEY INTERSTITIUM; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DAMAGE; MACROPHAGE; MEDIATOR RELEASE; MESANGIUM CELL; MONOCYTE; PATHOGENESIS; PROGNOSIS; PROPHYLAXIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEINURIA; REVIEW; TREATMENT PLANNING;

DISEASE PROGRESSION; EPITHELIAL CELLS; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; KIDNEY FAILURE, CHRONIC; KIDNEY TUBULES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2;

EID: 21744462285     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10157-004-0324-9     Document Type: Review

References (48)

1. Emancipator SN. IgA nephropathy: morphologic expression and pathogenesis. Am J Kidney Dis 1994;23:451-62.
2. Julian BA, Tomana M, Novak J, Mestecky J. Progress in the pathogenesis of IgA nephropathy. Adv Nephrol Necker Hosp 1999;29:53-72.
3. Schena FP. A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 1990;89:209-15.
4. Ibels LS, Gyory AZ. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine (Baltim) 1994;73:79-102.
5. Radford MG Jr, Donadio JV Jr, Bergstralh EJ, Grande JP. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997;8:199-207.
6. Fofi C, Pecci G, Galliani M, Comunian MC, Muda AO, Pierucci A, et al. IgA nephropathy: multivariate statistical analysis aimed at predicting outcome. J Nephrol 2001;14:280-5.
7. Burton C, Harris KP. The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 1996;27:765-75.
8. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998;339:1448-56.
9. Tomino Y, Sakai H. Clinical guidelines for immunoglobulin A nephropathy in Japan, second edition. Clin Exp Nephrol 2003;7:93-7.
10. Floege J, Feehally J. IgA nephropathy: recent developments. J Am Soc Nephrol 2000;11:2395-403.
11. Lai KN, Ho CP, Chan KW, Yan KW, Lai FM, Vallance-Owen J. Nephrotic range proteinuria - a good predictive index of disease in IgA nephropathy? Q J Med 1985;57:677-88.
12. Colasanti G, Banfi G, di Belgiojoso GB, Bertoli S, Fogazzi G, Ragni A, et al. Idiopathic IgA mesangial nephropathy: clinical features. Contrib Nephrol 1984;40:147-55.
13. Lai KN, Lai FM, Chan KW, Ho CP, Leung AC, Vallance-Owen J. An overlapping syndrome of IgA nephropathy and lipoid nephrosis. Am J Clin Pathol 1986;86:716-23.
14. D'Amico G. Clinical features and natural history in adults with IgA nephropathy. Am J Kidney Dis 1998;12:353-7.
15. Rychlik I, Andrassy K, Waldherr R, Zuna I, Tesar V, Jancova E, et al. Clinical features and natural history of IgA nephropathy. Ann Med Interne 1999;150:117-26.
16. D'Amico G, Imbasciati E, Barbiano Di Belgioioso G, Bertoli S, Fogazzi G, et al. Idiopathic IgA mesangial nephropathy. Clinical and histological study of 374 patients. Medicine (Baltim) 1985;64:49-60.
17. Freese P, Norden G, Nyberg G. Morphologic high-risk factors in IgA nephropathy. Nephron 1998;79:420-5.
18. Falk MC, Ng G, Zhang GY, Fanning GC, Roy LP, Bannister KM, et al. Infiltration of the kidney by alpha beta and gamma delta T cells: effect on progression in IgA nephropathy. Kidney Int 1995;47:177-85.
19. Lai KN, Tang SC, Guh JY, Chuang TD, Lam MF, Chan LY, et al. Polymeric IgA1 from IgA nephropathy upregulates synthesis and signal transduction of transforming growth factor-β in human mesangial cell via the renin-angiotensin system. J Am Soc Nephrol 2003;14:3127-37.
20. Wu Q, Jinde K, Endoh M, Sakai H. Clinical significance of costimulatory molecules CD80/CD86 expression in IgA nephropathy. Kidney Int 2004;65:888-96.
21. van Kooten C, Daha MR, van Es LA. Tubular epithelial cells: a critical cell type in the regulation of renal inflammatory processes. Exp Nephrol 1999;7:429-37.
22. Tang SC, Leung JCK, Abe K, Chan KW, Chan LY, Chan TM, et al. Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells: an in vitro and in vivo study. J Clin Invest 2003;111:515-27.
23. Tang S, Leung JC, Tsang AW, Lan HY, Chan TM, Lai KN. Transferrin up-regulates chemokine synthesis by human proximal tubular epithelial cells: implication on mechanism of tubuloglomerular communication in glomerulopathic proteinura. Kidney Int 2002;61:1655-65.
24. Galla JH, Spotswood MF, Harrison LA, Mestecky J. Urinary IgA in IgA nephropathy and Henoch-Schoenlein purpura. J Clin Immunol 1985;5:298-306.
25. Frasca GM, Vangelista A, Biagini G, Bonomini V. Immunological tubulo-interstitial deposits in IgA nephropathy. Kidney Int 1982;22:184-91.
26. Habib R, Niaudet P, Levy M. Schonlein-Henoch purpura nephritis and IgA nephropathy. In: Brenner B (ed) Renal pathology, with clinical and functional correlations. 2nd ed. Philadelphia: Lippincott; 1994. p. 472-523.
27. Frasca GM, Vangelista A, Biagini G, Bonomini V. Immunological tubulointerstitial deposits in IgA nephropathy. Kidney Int 1982;22:184-91.
28. Chan LY, Leung JCK, Tsang AW, Chan TM, Tang SC, Lai KN. Activation of human proximal renal tubular epithelial cells by mediators released from mesangial cells cultured with IgA. J Am Soc Nephrol 2003;14:375A.
29. Harrison-Bernard LM, Navar LG, Ho MM, Vinson GP, El-Dahr SS. Immuno-histochemical localization of Ang II AT1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol 1997;273:F170-7.
30. Ozono R, Wang ZQ, Moore AF, Inagami T, Siragy HM, Carey RM. Expression of the subtype 2 angiotensin AT2 receptor in rat kidney. Hypertension 1997;30:1238-46.
31. Wang L, Flannery P, Spurney RF. Characterization of angiotensin II-receptor subtypes in podocytes. J Lab Clin Med 2003;142:313-21.
32. Siragy HM. AT1 and AT2 receptor in the kidney: role in health and disease. Semin Nephrol 2004;24:93-100.
33. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J. Proinflammatory actions of angiotensin II. Curr Opin Nephrol Hypertens 2001;10:321-9.
34. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, et al. Renal injury from angiotensin II-mediated hypertension. Hypertension 1992;19:464-74.
35. Bhaskaran M, Reddy K, Radhakrishanan N, Franki N, Ding G, Singhal PC. Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol 2003;284:F955-65.
36. Wolf G. Angiotensin II and tubular development. Nephrol Dial Transplant 2002;17 (suppl 9):48-51.
37. Mezzano SA, Ruiz-Ortega M, Edigo J. Angiotensin II and renal fibrosis. Hypertension 2001;38:635-8.
38. Hale GM, Howarth GS, Aarons I, Clarkson AR, Woodroffe AJ. Quantitation of glomerular angiotensin II receptors in IgA nephropathy. Clin Nephrol 1989;32:5-9.
39. Wagner J, Gehlen F, Ciechanowicz A, Ritz E. Angiotensin II receptor type 1 gene expression in human glomerulonephritis and diabetes mellitus. J Am Soc Nephrol 1999;10:545-51.
40. Del Prete D, Gambaro G, Lupo A, Anglani F, Brezzi B, Magistroni R, et al. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulone-phritis. Kidney Int 2003;64:149-59.
41. Lai KN, Chan LYY, Tang SC, Tsang AW, Li FK, Lam MF, et al. Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1. Kidney Int (in press).
42. Makita N, Iwai N, Inagami T, Badr K. Two distinct pathways in the down-regulation of type-1 angiotensin II receptor gene in rat glomerular mesangial cells. Biochem Biophys Res Commun 1992;185:142-6.
43. Chansel D, Bizet T, Vandermeersch S, Pham P, Levy B, Ardaillou R. Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells. Am J Physiol 1994;266:F384-93.
44. Ma J, Matsusaka T, Yang H, Kawachi H, Shimizu F, Isaka Y, et al. Local actions of endogenous angiotensin II in injured glomeruli. J Am Soc Nephrol 2004;15:1268-76.
45. Weidekamm C, Hauser P, Hansmann C, Schwarz C, Klingler H, Mayer G, et al. Effect of AT1 and AT2 receptor blockade on angiotensin II induced apoptosis of human renal proximal tubular epithelial cells. Wien Klin Wochenschr 2002;114:725-9.
46. Panchapakesan U, Pollock CA, Chen XM. The effect of high glucose and peroxisome proliferator-activated receptor gamma agonists on PPAR-gamma expression and function in HK-2 cells. Am J Physiol Ren Physiol 2004; April 27 [Epub].
47. Carey RM, Howell NL, Jin X-H, Siragy HM. Angiotensin type-2 receptor-mediated hypotension in angiotensin type-1 receptor blocked rats. Hypertension 2001;38:1272-7.
48. Wan Y, Wallinder C, Johansson B, Holm M, Mahalingam AK, Wu X, et al. First reported nonpeptide AT1 receptor agonist (L-162,313) acts as an AT2 receptor agonist in vivo. J Med Chem 2004;47:1536-46.